Delivery Order SPE2D021DA002-SPE2D324F093F

Award Date 7/3/24
Potential Completion Date 7/5/24
Potential Value $1.5K
Federal Agency
Medical Supply Chain
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $1,767.06, was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is a firm fixed-price delivery order for the supply of ADACEL TDAP VIAL, a specialized pharmaceutical product, with a completion date of November 29, 2024. The contract award is not associated with any set-aside designation, allowing DMS Pharmaceutical Group to...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $1,472.55, is for the delivery of ADACEL TDAP VIAL, a pharmaceutical product. The award is part of a larger single-award indefinite delivery contract (IDC) between DMS Pharmaceutical Group and DLA under the SPE2DB program, valued at up to $499,999,999 and running...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $1,612.72 contract is for the delivery of ADACEL TDAP VIAL, a pharmaceutical product, with a final completion date of June 12, 2024. The award is issued under DMS Pharmaceutical Group's larger $499,999,999 indefinite delivery contract (IDC) with the DLA, which allows the agency to...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to DMS Pharmaceutical Group Inc., a woman-owned small business. The $1,437.20 order is for the supply of the pharmaceutical product ADACEL TDAP VIAL. DMS Pharmaceutical Group holds various federal contracts and indefinite delivery vehicles (IDVs) with the DLA Troop Support Medical to provide a wide range of pharmaceutical and medical supplies, such as flumazenil injection, prednisone...
This firm fixed price delivery order was awarded by the Defense Logistics Agency (DLA) Troop Support Medical to DMS Pharmaceutical Group Inc., a woman-owned small business. The contract has a potential value of $1,734.48 and a completion date of August 10, 2023. The order is for the supply of Adacel Tdap Vial, a pharmaceutical product, to support the medical needs of the U.S. military. DMS Pharmaceutical Group is an experienced federal contractor that holds multiple indefinite delivery contracts...
<p>The Defense Logistics Agency Troop Support Medical awarded a Firm Fixed Price delivery order to DMS Pharmaceutical Group Inc., a Woman-Owned Small Business, to provide Adacel TDAP Vial in the amount of $1,437.20. This delivery order was issued against an existing Indefinite Delivery Contract with DMS Pharmaceutical Group to supply a variety of pharmaceutical and medical products to support military treatment facilities worldwide. The contract does not have a set-aside designation.</p>
The U.S. Department of Defense, through the Defense Logistics Agency (DLA), has awarded a firm fixed-price delivery order contract worth $1,147.00 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the provision of Tetanus/Diphtheria vaccines and medical supplies to support the recurring medical needs of military healthcare facilities. This delivery order is issued under DMS Pharmaceutical Group's existing...
This is a federal contract award from the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The contract is a $3,145.80 firm fixed-price delivery order for the supply of BOOSTRIX TDAP VACCINE SYRINGE 0.5ML, a specialized pharmaceutical product. The contract has an ultimate completion date of January 22, 2025 and was awarded on January 21, 2025. DMS Pharmaceutical Group Inc. holds a significant $499,999,999 Indefinite Delivery...
This federal contract award, valued at $1,772.20, was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is a delivery order under a larger indefinite delivery contract (IDC) with the DLA valued at up to $499,999,999, which runs through December 31, 2025. This IDC allows the DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency Troop Support Medical to DMS Pharmaceutical Group Inc., a for-profit, woman-owned small business based in Park Ridge, Illinois. The contract, valued at $1,043.25, is for the delivery of DAPTACEL PF VACC 10S pharmaceuticals with a completion date of February 22, 2024. This order is issued against DMS Pharmaceutical Group's larger indefinite delivery contract 4600082013 under the SPE2DB program with the Defense...
  • SPE2D021DA002
    Indefinite Delivery Contract
  • SPE2D021DA002-SPE2D324F093F
    Delivery Order

This is a federal contract award from the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $1,523.80, is for the delivery of ADACEL TDAP Vial, a pharmaceutical product.

The award is issued as a delivery order under a larger indefinite delivery contract (IDC) that DMS Pharmaceutical Group holds with the DLA, valued at up to $499,999,999. This single-award IDC, under the SPE2DB program, allows the DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical items to fulfill the recurring medical supply needs of military health facilities worldwide.

This contract does not have a set-aside designation. DMS Pharmaceutical Group's status as a woman-owned small business has enabled it to secure direct awards for pharmaceutical Prime Vendor programs supporting military medical facilities globally.

Generated 10/2/24, 10:21 AM